四川美豐(000731.SZ):化肥分公司生產裝置檢修完成開車運行
格隆匯1月17日丨四川美豐(000731.SZ)公佈,公司於2023年11月14日發佈《關於化肥分公司生產裝置進行例行年度檢修的公吿》(公吿編號:2023-70),內容為:“根據生產工藝特點,結合生產裝置運行週期情況,為確保生產裝置安全穩定運行,定於近日對分公司-四川美豐化肥分公司的生產裝置進行例行年度檢修,實施優化消缺。本次檢修及開停車時間預計兩個月左右,預計將影響尿素產量約6.7萬噸。”
截至公吿披露日,化肥分公司生產裝置已全面完成檢修並恢復正常生產。停車檢修期間,公司對生產裝置進行了例行的設備檢驗檢測和維護保養,以確保裝置的安全平穩長週期運行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.